ALS Rating Reiterated by JPMorgan Chase & Co. (ALQ)
ALS (ASX:ALQ)‘s stock had its “underweight” rating restated by research analysts at JPMorgan Chase & Co. in a report released on Monday, ARN reports. They currently have a $6.95 target price on the stock.
ALS (ASX:ALQ) traded up 1.05% during mid-day trading on Monday, hitting A$7.710. The stock had a trading volume of 1,050,074 shares. ALS has a 1-year low of A$7.050 and a 1-year high of A$10.640. The stock has a 50-day moving average of A$7.37 and a 200-day moving average of A$8.4. The company has a market cap of A$2.780 billion and a P/E ratio of 14.10.
ALQ has been the subject of a number of other recent research reports. Analysts at Morningstar raised their price target on shares of ALS to $8.55 in a research note on Wednesday, February 12th. They now have a “hold” rating on the stock.
ALS Limited, formerly Campbell Brothers Limited, is engaged in the provision of technical testing and inspection services specifically supporting mining and mineral exploration, commodity certification, environmental monitoring, equipment maintenance, food and pharmaceutical quality assurance and industrial operations; distribution of cleaning agents and chemicals for both domestic and industrial customers, and distribution of non-food consumables to the healthcare, building services, hospitality and leisure industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.